Computational drug repurposing for CDKL5 Deficiency Disorder

Awardee: Diego Di Bernardo, PhD

Institution: Telethon Institute of Genetics and Medicine

Award Amount: $150,000

Funding Period: May 1, 2022 - April 31, 2023

Previous
Previous

Utilizing patient iPSC-derived neurons to determine the functional consequences of longer cilia in CDKL5 Deficiency Disorder (CDD)

Next
Next

Rescuing functional defects in a zebrafish model of CDKL5 deficiency: Contribution to the identification of therapeutic target